# The Use of Quetiapine (Seroquel) in the Treatment of Social Phobia: Public Speaking Environment

> **NCT00407199** · PHASE4 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 20 (actual)

## Conditions studied

- Social Phobia

## Interventions

- **DRUG:** quetiapine

## Key facts

- **NCT ID:** NCT00407199
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2011-10-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00407199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00407199, "The Use of Quetiapine (Seroquel) in the Treatment of Social Phobia: Public Speaking Environment". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00407199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*